Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy

Molecular Therapy(2023)10.1016/j.ymthe.2023.01.012Source: DataRank Database

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy is a research paper published in Molecular Therapy (2023). On theSindex it has a DataRank of 0. It has been cited 59 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access59 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 6.79)OA: greenTopics (58)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (28)

Silvia Beghi ORCID,Marco Ruella ORCID,Kalpana Parvathaneni ORCID,Silvano Salaris ORCID,Νεκτάριος Κωστόπουλος ORCID

Live enrichment

PubMed:36641624 OpenAlex:https://openalex.org/W4315977392

National Cancer Institute

Grant: 1R01CA219871-01 A1

National Cancer Institute

Grant: 5R01CA206012-04

National Blood Foundation

Grant: 2019-BP-00204

European Commission

Grant: 801370

Beatriu de Pinos-3 Postdoctoral Programme

NCI NIH HHS

Grant: P01 CA214278

NCI NIH HHS

Grant: R01 CA206012

NCI NIH HHS

Grant: R01 CA219871

NCI NIH HHS

Grant: R37 CA262362

FWCI

6.79

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: CC BY NC ND

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10014349/pdf/main.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525001623000126?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001623000126?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10014349

Fields of Study

CAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmune Cell Function and Interaction0301 basic medicine03 medical and health sciences0302 clinical medicineHumansMiceAnimalsReceptors, Antigen, T-CellCross-PrimingGastrointestinal MicrobiomeVancomycinImmunotherapyT-LymphocytesImmunotherapy, AdoptiveReceptors, Chimeric AntigenAntigens, CD19

MeSH Terms

Gastrointestinal MicrobiomeReceptors, Chimeric AntigenAnimalsHumansImmunotherapyReceptors, Antigen, T-CellT-LymphocytesVancomycinImmunotherapy, AdoptiveAntigens, CD19Cross-PrimingMice

Keywords

Chimeric antigen receptorImmunotherapyT cellCartImmunologyCancer immunotherapyCD19Cancer researchAntigenMedicineCancerBiologyImmune systemInternal medicineReceptors, Chimeric AntigenT-LymphocytesAntigens, CD19Receptors, Antigen, T-CellImmunotherapy, AdoptiveGastrointestinal MicrobiomeMiceCross-PrimingVancomycinHumansAnimalsCAR T cellantigen cross-presentationgut microbiota

Sustainable Development Goals

SDG 0: Good health and well-being